Research programme: cardiovascular therapies - Forbes Medi-Tech
Alternative Names: FM VA12; FM VP24; FM VPx Library of CompoundsLatest Information Update: 27 May 2008
At a glance
- Originator Forbes Medi-Tech
- Class
- Mechanism of Action Cholesterol absorption inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Atherosclerosis; Cardiovascular disorders
Most Recent Events
- 27 May 2008 Discontinued - Preclinical for Atherosclerosis in Canada (unspecified route)
- 27 May 2008 Discontinued - Preclinical for Cardiovascular disorders in Canada (unspecified route)
- 01 Mar 2006 This programme is still in active development - (4th Annual BioPartnering North America (BPN-2006))